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I
t can be difficult to obtain sufficient margins 
for extremity soft tissue sarcomas (ESTSs) in 
proximity to important structures even when 
preoperative external beam radiation therapy 
(EBRT) is used. Postoperative brachytherapy can 
be added in an attempt to decrease the risk of local 
recurrence. High-dose-rate brachytherapy using 
computer optimized treatment planning provides 
a uniform dose to the target and very low doses to 
nearby radiosensitive tissues.
Rates of major wound complications following 
preoperative EBRT range from 19% to 52% for pa-
tients with ESTS who receive a vascularized flap.1–3 It 
is possible that adding postoperative brachytherapy 
might make this rate higher. However, the desire to 
prevent recurrence and retain a functional limb may 
justify this risk.
METHODS
A 71-year-old man presented to his primary care 
physician with a nontender subcutaneous mass of 
the right medial arm. Magnetic resonance imaging 
(MRI) showed a 7.4  ×  2.9  ×  7.0  cm mass which abut-
ted the biceps muscle, brachial artery, and median 
nerve. Incisional biopsy demonstrated myxofibrosar-
coma, intermediate grade. Chest computed tomog-
raphy scan showed no evidence of metastatic disease. 
He was staged as G2T2aN0M0, stage IIB.
External Beam Radiation
Due to the high propensity for myxofibrosarcoma 
to recur locally4 and the lesion’s proximity to neuro-
vascular structures, preoperative EBRT was offered. 
A dose of 50 Gy in 2 Gy daily fractions was given over 
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Summary: A 71-year-old man was found to have a 7.4 × 2.9 × 7.0 cm myxo-
fibrosarcoma of the right medial arm close to neurovascular structures. 
He received 50 Gray (Gy) of preoperative external beam radiation. Radi-
cal resection resulted in a 15  ×  10  cm defect. Nine brachytherapy cath-
eters were placed, and a pedicled latissimus dorsi myocutaneous flap was 
used in reconstruction. Final pathology confirmed myxofibrosarcoma, 
high grade. The tumor was <1 mm from 2 margins. A total of 17.5 Gy of 
brachytherapy was delivered to the surgical bed from postoperative days 
7 to 9. The flap developed fat necrosis distally which eventually required 
surgical debridement on postoperative day 58. It subsequently healed 
well and maintained good function of the limb. The patient remains 
under surveillance without evidence of recurrence. (Plast Reconstr Surg 
Glob Open 2014; 2: e229; doi: 10.1097/GOX.0000000000000188; Published 
online 9 October 2014).
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5 weeks (Fig. 1). The only side effects were mild, in-
field skin erythema, and ipsilateral axillary alopecia.
Surgical Resection
Five weeks after completion of EBRT, the patient 
underwent radical resection of the right arm mass. 
A 2-cm margin of skin was encompassed beyond ra-
diographic extent of the tumor based on MRI and 
extended circumferentially 1–2  cm into subcutane-
ous tissue. A portion of the superficial biceps muscle 
was excised as part of the deep margin. The brachial 
artery and basilic vein were spared. The closest mar-
gin was the medial aspect of the deep margin over 
the spared median, medial antebrachial cutaneous, 
and ulnar nerves. There was no macroscopic involve-
ment of any of the margins. The postresection defect 
measured 15 × 10 cm (Fig. 2).
Brachytherapy Catheter Placement
Intraoperative frozen sections suggested that the 
median nerve margin was <2  mm. Nine 6F brachy-
therapy catheters were serially introduced through 
the skin with blunt trocars from an inferior lateral 
approach (Fig. 3). They were fixed to the tumor bed 
with chromic gut interrupted suture. The external 
portions were secured to the skin using buttons, 
spacers, and interrupted 3-0 nylon suture. They were 
gathered together with a Penrose drain (Cardinal 
Health, Dublin, OH) and covered with Xeroform 
gauze (Covidien, Mansfield, MA).
Reconstruction
A latissimus dorsi myocutaneous flap was de-
signed intraoperatively to fill the defect and cover 
the exposed neurovascular structures while preserv-
ing motion of the extremity. The flap was elevated 
and tunneled through the axilla. Two 15F Blake 
drains were placed at the donor site which was pri-
marily closed. The patient was then repositioned for 
reconstruction of the defect.
The recipient site was undermined laterally and 
posteriorly to accommodate redundant bulk of the 
muscle in the flap. A 0.5-in Penrose drain was placed 
under the flap via the axilla. The skin island was 
trimmed distally to accommodate the insertion of 
the flap, and the recipient site was closed in layered 
fashion with interrupted then running 3-0 Monocryl 
(Ethicon, Somerville, NJ). The flap was pink and vi-
able leaving the operating room.
Pathology
The  tumor  measured  5.5 × 4.0 × 2.0 cm.  Micro-
scopic analysis confirmed myxofibrosarcoma, high 
grade. The tumor invaded beyond the fascia and was 
Fig. 1. external beam radiation dose distribution.
Fig. 2. Intraoperative photography demonstrates the tumor 
reflected en bloc exposing the brachial artery (forceps), par-
tially resected biceps muscle, and basilic vein (loop).
Fig. 3. Brachytherapy catheters on the tumor bed. Nine cath-
eters were inserted through the skin inferior to the defect and 
secured to the tumor bed and skin before flap   placement. 
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<1 mm from the deep/posterior margin. The tumor 
was also <1  mm from the median nerve margin but 
bounded by fascia. The lateral margin was 2.1 cm, in-
ferior margin 0.6 cm, and proximal margin 2.1 cm.
Five days postoperatively, the case was presented 
at multidisciplinary sarcoma pathology conference, 
where brachytherapy boost was recommended.
Brachytherapy
A complex computed tomography target plan 
was designed to deliver a total of 17.5 Gy in fractions 
of 3.5 Gy to the surgical bed with a 2-cm peripher-
al margin and a depth of 5  mm (Fig. 4). Including 
preoperative EBRT, this represented a total radio-
biologically equivalent dose of 70 Gy. Brachytherapy 
was delivered in 5 mm steps using a Nucletron HDR 
MicroSelectron Apparatus (Elektra, Norcross, GA) 
twice a day from postoperative days 7 to 9.
Wound Management
At discharge, the distal portion of the flap was 
slightly dusky. Hyperbaric oxygen was prescribed, 
but delayed and interrupted. One month following 
resection, the flap developed erythema around the 
edge and a draining area of fat necrosis undermined 
the distal, dusky area. This was managed conserva-
tively, but eventually required surgical debridement 
on postoperative day 58. A 5  ×  2 × 2  cm area of the 
distal flap was debrided, and a vacuum-assisted clo-
sure was placed. Hyperbaric oxygen treatments con-
tinued, totaling 20, and the vacuum-assisted closure 
was removed after 27 days with great improvement. 
The wound subsequently healed (Fig. 5).
The patient is currently under surveillance.
DISCUSSION
The chance of a major wound complication was 
high for this patient. However, preoperative EBRT 
with postoperative brachytherapy was thought to 
provide the best chance of local control and func-
tional limb preservation in this high-risk situation. 
Poor healing required return to the operating room, 
but the flap remained viable. There are only a few 
reports in the literature describing patients treated 
with EBRT, surgical resection, primary reconstruc-
tive flap closure, and boost brachytherapy for pri-
mary treatment of ESTS.1,5 Although these cases 
demonstrate that reconstruction can be successful 
with acceptable complications, the risks and benefits 
are not certain. A multi-institution registry may be 
warranted to better track outcomes because the low 
number of like patients limits possible studies.
CONCLUSIONS
This report describes a 71-year-old man with 
a high-grade myxofibrosarcoma of the upper arm 
abutting neurovascular structures who was treated 
with 50 Gy of preoperative EBRT, radical resection, 
a primary latissimus dorsi flap, and 17.5 Gy boost of 
HDR brachytherapy. The postoperative course was 
complicated by partial flap necrosis requiring op-
erative debridement; however, the flap remained vi-
able, and he retained excellent function of the arm. 
An MRI at 3 months postresection showed no evi-
dence of local recurrence. This case demonstrates 
that even with the use of preoperative radiation and 
Fig. 4. Highly conformal brachytherapy dose distribution. 
Yellow indicates the 100% isodose line.
Fig. 5. Follow-up photography at 5 months after resection 
demonstrates excellent healing, range of motion, and no evi-
dence of recurrence.4
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boost brachytherapy, a vascular flap can remain vi-
able, allowing for limb salvage with good function. 
We feel the potential morbidities of this technique 
are justified for patients at very high risk for local 
recurrence and potential subsequent loss of limb. 
Phillip M. Devlin, MD, FACR, FASTRO
Division of Brachytherapy
Brigham and Women’s Hospital
75 Francis Street, Boston
MA 02115
E-mail: pdevlin@lroc.harvard.edu 
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